Stocks to Watch: Bancroft Uranium Inc (OTC BB: BCFT), Genta Incorporated (Nasdaq: GNTA), Golden Eagle International, Inc. (OTC BB:MYNG), Micromem Technologies Inc. (OTC BB:MMTIF), Argyle Security Acquisition Corporation (OTC BB:ARGL)
Featured Stock: Bancroft Uranium Inc
(OTC BB: BCFT)
Current Price (0.89)
http://www.smallcapstockanalyst.com/
Bancroft Uranium Embraces Environmental Principals
SCOTTSDALE, AZ-- Jun 2, 2008 -- Bancroft Uranium Inc. (OTC BB:BCFT.OB - News) ("Bancroft" or the "Company") today wishes to advise the public as to the Company's strong ongoing commitment to environmental principals, the health of its workers, the community and to the overall protection of the environment.
Bancroft believes that the production of emissions-free electricity via nuclear power generation is the only form of energy for the future that can have a significant, beneficial near-term impact on reducing fossil fuel dependence thus decreasing carbon emissions and as a result, having a positive affect on climate change.
Going forward, in the event of a production decision, Bancroft would be subject to and would need to comply with substantive environmental regulations. In Canada, the Canadian Nuclear Safety Commission is the national regulatory body as well as other stringent Federal and Provincial regulations such as those that come under the Canadian Environmental Protection Act, The Fisheries Act, The Environmental Management and Protection Act, The Clean Air Regulations and The Mineral Industry Environmental Protection Regulations, just to mention a few.
Additionally, in direct response to past practices, mining law now requires mine operators to reclaim land disturbed by mining. Bancroft will be required to incorporate reclamation and decommissioning plans as part of the Environmental Impact Study that will form part of Bancroft's application for a mining license. The Company will also be required to post a bond to guarantee reclamation of all public and private lands.
With respect to safety of our workers, Bancroft requires all employees at the Monmouth project site to wear dosimeters which are regularly monitored. Routine monitoring of air, dust and surface conditions will also be instituted. If the Monmouth Project goes into production it will be utilizing a gravity separation milling process which utilizes a closed water system which would be recycled, reused and thoroughly cleaned. Metallurgy has shown that 91.4% of the U3O8 can be removed by a first pass, simple gravity circuit. No hazardous chemicals are envisioned to be used in this process.
The Company also intends to apply for I.S.O. certification in accordance with the I.S.O. 14001 standard for environmental management systems. In short, Bancroft is convinced that it can conduct mining operations in a completely safe and sustainable manner on an ongoing basis that will meet standard environmental protection practices.
For inquiries from the public and media concerning the Monmouth Uranium Project please contact Greenspirit Strategies at 1-877-54 GREEN or 1-877-544-7336. For shareholder and investor information please contact investor relations at 1-866-860-2995.
ABOUT BANCROFT URANIUM INC. (OTC BB:BCFT.OB - News)
Bancroft Uranium Inc. is an exploration Company which intends to develop Uranium assets in North America. Bancroft's initial asset, the Monmouth Uranium Project is envisioned to have the potential of a low cost, open pit uranium producer located close to infrastructure and end product buyers.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements", as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of our exploration program at our uranium properties and any anticipated future production. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with mineral exploration and development stage exploration companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-KSB for the most recent fiscal year, our quarterly reports on Form 10-QSB and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
Bancroft Uranium Inc.
- - - - - - - - - - - - - - - - - -
P. L. Hammond, C.A.
President and Chief Executive Officer
To find out more about Bancroft Uranium Inc. (OTC BB:BCFT.OB - News), visit our website at http://www.bancrofturanium.com/.
Contact:
Public and Media Information:
1-877-544-7336
Shareholder and Investor Information:
1-866-860-2995
Source: Bancroft Uranium Inc.
For an in-depth analyst report, please visit : http://www.smallcapstockanalyst.com/
Genta Incorporated
(Nasdaq: GNTA)
Current Price (0.35)
www.SmallCapStockAnalyst.com
BERKELEY HEIGHTS, N.J., May 30 - Genta Incorporated (OTC Bulletin Board: GNTA - News) announced preliminary results that have shown a high objective response rate in a pilot study that incorporates the Company's lead oncology product, Genasense® (oblimersen sodium) Injection, in a chemotherapy program for patients with advanced melanoma. In this study, Genasense was used to potentially enhance the clinical activity of temozolomide (Temodar®; Schering Plough, Inc.), the most commonly used anticancer drug for melanoma, combined with Abraxane® (paclitaxel protein-bound particles for injectable suspension; Abraxis Bioscience, Inc.). The data will be featured in a presentation at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago on June 1, 2008. Genta Incorporated engages in the identification, development, and commercialization of drugs for the treatment of cancer and related diseases in the United States. The company’s research portfolio consists of two major programs: DNA/RNA Medicines and Small Molecules. The DNA/RNA Medicines program includes drugs that are based on using modifications of either DNA or RNA as drugs that can be used to treat disease. This program includes technologies, such as antisense, decoys, aptamers, and small interfering or micro RNA. Its product Genasense, designed to block the production of a protein known as Bcl-2, which is used for the treatment of malignant melanoma, chronic lymphocytic leukemia, multiple myeloma, acute myelocytic leukemia, nonsmall-cell lung cancer, prostate cancer, small-cell lung cancer, breast cancer, colorectal cancer, nonHodgkin’s lymphoma, kidney cancer, pancreatic cancer, Waldenstrom’s macroglobulinemia, hepatocellular carcinoma, and childhood solid tumors. The Small Molecules program includes drugs that are based on gallium-containing compounds. Its product Ganite, a phase II product that is used as a treatment for cancer-related hypercalcemia that is resistant to hydration used primarily for patients with malignant lymphoma, bladder cancer, nonHodgkin’s lymphoma, and other cancer types. Genta was founded in 1988 and is based in Berkeley Heights, New Jersey.
Golden Eagle International, Inc.
(OTC BB:MYNG)
Current Price (0.006)
www.SmallCapStockAnalyst.com
SALT LAKE CITY, UT---May 30, 2008 -- Golden Eagle International, Inc. (OTC BB:MYNG.OB - News) today reported that it is in the final stage of construction of its C Zone gold mill in eastern Bolivia. The Company estimates that the C Zone gold mill will begin its preliminary shake-out operations within the first 10 days of June and will commence its initial production phase at 200 tpd of mineralized material before the end of June 2008. Golden Eagle intends to incrementally expand its C Zone gold mill over the first 6 months of operations to a final projected capacity of 2,000 tpd. Golden Eagle International, Inc. is a gold and copper exploration and mining company headquartered in Salt Lake City, Utah and with offices also in Santa Cruz, Bolivia. The Company is concentrating its efforts on expanding its pilot operations into production operations on its gold project on the C Zone within its 136,500 acres (213 square miles) in eastern Bolivia's Precambrian Shield. In addition, the Company is working with Washington Group International, Inc. on a due diligence study on the Company's A Zone Buen Futuro gold and copper project.
Micromem Technologies Inc.
(OTC BB:MMTIF)
Current Price (1.74)
www.SmallCapStockAnalyst.com
TORONTO, May 30 - Micromem Technologies Inc. (OTC BB: MMTIF - News; "Micromem" or the "Company") announces that its Board of Directors has adopted a shareholder rights plan (the "Rights Plan"). The Rights Plan, which took effect May 29, 2008, has been adopted to ensure the fair treatment of shareholders in the event of any take-over offer for the Company's common shares. Micromem Technologies, Inc. (www.micromeminc.com) is focused on the development of magnetic random access memory (MRAM) technology. We believe that once fully developed, this technology will be suitable for various applications including, without limitation, Radio Frequency Identification (RFID). It is anticipated that RFID will be Micromem's first market objective. Micromem's primary technology was developed pursuant to an exclusive world wide commercial license issued by the University of Toronto ("UT"). Pursuant to the terms of the license, Micromem can buy out the balance of its financial obligations with respect to the patents and technology licensed by UT for a fixed fee. The MRAM development work was undertaken in accordance with research collaboration agreements among Micromem, the University of Toronto, Dr. Harry Ruda and OCE Inc., a not-for-profit corporation supported through the Ontario Ministry of Economic Development and Trade's (MEDT) Ontario Centres of Excellence program.
Argyle Security Acquisition Corporation
(OTC BB:ARGL)
Current Price (6.15)
www.SmallCapStockAnalyst.com
SAN ANTONIO--May 30--Argyle Security, Inc., (OTC BB:ARGL - News), (“Argyle”) a service and solutions provider in the physical electronic security industry, announced today that it is scheduled to present at RedChip’s upcoming Small Cap Investor Conference on Thursday, June 5, 2008 at 3 P.M. Pacific Time. The event will be held at the Palace Hotel in San Francisco, California. Argyle Security was established as a special purpose acquisition corporation with the objective of effecting a merger, capital stock exchange, asset acquisition or other business combination with an unidentified operating business in the security industry. Argyle Security's goal is to become a leading global company that provides solutions for the physical electronic security industry. Its channel focus will be Video Surveillance, Access Control, Perimeter/Outdoor Protection, Intrusion Protection, Fire Detection and Threat Analysis, serving selected commercial, governmental and residential markets. Argyle Security was co-founded by Messrs. Marbut and Chaimovski. In addition to Messrs. Marbut and Chaimovski, Argyle's founding Board of Directors includes Gen. Wesley K. Clark and Mr. John J. (Chip) Smith.
Smallcapstockanalyst.com is owned and operated by Iron Consulting LLC
Verify all claims and do your own due diligence. Iron Consulting profiles are not a solicitation or recommendation to buy, sell or hold securities. Iron Consulting is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Iron Consulting is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), Smallcapstockanalyst.com is owned and operated by Iron Consulting. Iron Consulting www.ironconsultinginc.com has receive fifty thousand dollars from Equity Alliance Intl. for one months of internet marketing services, from Equity Alliance Int. LLC www.equityallianceir.com for its marketing and consulting services. Neither Iron Consulting nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Iron Consulting receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Iron Consulting statements and opinions and such statements and opinions cannot be considered independent. Iron Consulting and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements ar e made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Iron Consulting services are often paid for using free-trading shares. Iron Consulting may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.